✦ LIBER ✦

High-dose ursodeoxycholic acid in the treatment of primary sclerosing cholangitis: Throwing the urso out with the bathwater?

✍ Scribed by Roger W. Chapman

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 63 KB
Volume: 50
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.23174

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose ursodeoxycholic acid for the t

High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

✍ Keith D. Lindor; Kris V. Kowdley; Velimir A. C. Luketic; M. Edwyn Harrison; Timo 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 319 KB 👁 1 views

Previous controlled trials are inconclusive regarding the efficacy of ursodeoxycholic acid (UDCA) for treating primary sclerosing cholangitis (PSC). One hundred fifty adult patients with PSC were enrolled in a long-term, randomized, double-blind controlled trial of highdose UDCA (28-30 mg/kg/day) ve

Oral budesonide in the treatment of pati

Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid

✍ Paul Angulo; Roberta A. Jorgensen; Jill C. Keach; E. Rolland Dickson; Coleman Sm 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 236 KB 👁 1 views

Ursodeoxycholic acid (UDCA) is a safe and effective medical therapy for most patients with primary biliary cirrhosis (PBC). However, some patients show an incomplete response to UDCA therapy. Treatment with corticosteroids may be of benefit although at the expense of systemic side effects. Budesonid

Salvage therapy with high-dose chemother

Salvage therapy with high-dose chemotherapy and autologous bone marrow support in the treatment of primary nonseminomatous mediastinal germ cell tumors

✍ E. R. Broun; C. R. Nichols; L. H. Einhorn; G. J. K. Tricot 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 268 KB 👁 2 views